| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
|
|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-1,033.3140 | -1,078.2620 | -2,357.4070 | -2,647.2790 |
|
Research and Development Expenses
|
-187.4390 | -212.8330 | -128.7690 | -160.9770 |
| Depreciation, Amortization and Depletion
|
-325.6000 | -325.6000 | -325.2840 | -73 |
| Other Income/Expense, Operating
|
243.1750 | 108.0490 | -364.3250 | -160.6390 |
|
Operating Income/Expenses
|
-1,303.1780 | -1,508.6460 | -3,175.7850 | -3,041.8950 |
|
Total Operating Profit/Loss
|
-1,303.1780 | -1,508.6460 | -3,175.7850 | -3,041.8950 |
| Total Net Finance Income/Expense
|
-37.8160 | -40.8700 | 7.0430 | -51.1010 |
| Net Investment Income
|
-- | -- | -- | -1.0360 |
| Irregular Income/Expenses
|
-33.3420 | -33.3420 | 102.7960 | -7,043.3680 |
|
Non-Operating Income/Expenses, Total
|
-71.1580 | -74.2120 | 109.8390 | -7,094.4690 |
|
Pretax Income
|
-1,374.3360 | -1,582.8580 | -3,065.9460 | -10,136.3640 |
|
Net Income from Continuing Operations
|
-1,374.3360 | -1,582.8580 | -3,065.9460 | -10,136.3640 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,374.3360 | -1,582.8580 | -3,065.9460 | -10,136.3640 |
|
Net Income after Non-Controlling/Minority Interests
|
-1,374.3360 | -1,582.8580 | -3,065.9460 | -10,136.3640 |
|
Net Income Available to Common Stockholders
|
-1,374.3360 | -1,582.8580 | -3,065.9460 | -10,136.3640 |
|
Diluted Net Income Available to Common Stockholders
|
-1,374.3360 | -1,582.8580 | -3,065.9460 | -10,136.3640 |
| Basic EPS
|
-0.02 | -0.02 | -0.05 | -0.22 |
| Diluted EPS
|
-0.02 | -0.02 | -0.05 | -0.22 |
|
Basic Weighted Average Shares Outstanding
|
95,017.1820 | 80,817.1820 | 64,544.9370 | 46,168.2210 |
|
Diluted Weighted Average Shares Outstanding
|
95,017.1820 | 80,817.1820 | 64,544.9370 | 46,168.2210 |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-1,336.5200 | -1,541.9880 | -3,072.9890 | -10,085.2630 |
|
EBITDA
|
-1,010.5200 | -1,216.3880 | -2,747.7050 | -10,012.2630 |
|
Normalized EBITDA
|
-1,066.5260 | -1,138.2610 | -1,527.6540 | -1,417.9730 |
|
Normalized Income
|
-1,430.3420 | -1,504.7310 | -3,175.7850 | -3,092.9960 |
|
Total Unusual Items
|
-56.0060 | 78.1270 | 1,220.0510 | 8,594.2900 |
|
Total Unusual Items Excluding Goodwill
|
-56.0060 | 78.1270 | 1,220.0510 | 8,594.2900 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 |
12/31/2023 - 8/9/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade